CoChat

Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies

Rees, Karen, Stowe, Rebecca, Patel, Smitaa, Ives, Natalie, Breen, Kieran, Clarke, Carl E, Ben-Shlomo, Yoav · 2010 · Cochrane Database of Systematic Reviews
Cited by 120

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: We will address the following questions: 1) Do NSAIDs prevent the onset of Parkinson's disease(PD)? We will seek primary prevention trials and epidemiological studies examining the association between NSAIDs and PD to address this question. 2) Are NSAIDs neuroprotective in PD ‐ do they slow the progression of disease once PD is established? We will seek secondary prevention trials to address this question. We will also explore any adverse effects of taking NSAIDs. 3) What are the adverse effects of taking NSAIDs in PD? We will use studies in question 2 above to examine this, along with any additional studies identified from the searching (including case studies and case series).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd008454

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 19

  1. 2008, Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial, Lancet Neurology, 7, 41, 10.1016/S1474-4422(07)70293-4 · DOI
  2. Aisen, 2002, Randomized pilot study of nimesulide treatment in Alzheimer's disease, Neurology, 58, 1050, 10.1212/WNL.58.7.1050 · DOI · Paper page
  3. Asanuma, 2007, Common anti-inflammatory drugs are potentially therapeutic for Parkinson's disease?, Experimental Neurology, 206, 172, 10.1016/j.expneurol.2007.05.006 · DOI
  4. Asanuma, 2008, Nonsteroidal anti-inflammatory drugs in experimental parkinsonian models and Parkinson's disease, Current Pharmaceutical Design, 14, 1428, 10.2174/138161208784480153 · DOI
  5. Breitner, 2009, Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort, Neurology, 72, 1899, 10.1212/WNL.0b013e3181a18691 · DOI · Paper page
  6. Reeves, 2008, Chapter 13: Including non-randomised studies, 10.1002/9780470712184.ch13 · DOI · Paper page
  7. de-Craen, 2005, Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia, American Journal of Epidemiology, 161, 114, 10.1093/aje/kwi029 · DOI · Paper page
  8. Esposito, 2007, Non-steroidal anti-inflammatory drugs in Parkinson's disease, Exp.Neurol., 205, 295, 10.1016/j.expneurol.2007.02.008 · DOI · Paper page
  9. Etminan, 2003, Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies, BMJ, 327, 128, 10.1136/bmj.327.7407.128 · DOI · Paper page
  10. Hernan, 2006, Non-steroidal antiinflammatory drugs and the incidence of Parkinson's disease, Neurology, 66, 1097, 10.1212/01.wnl.0000204446.82823.28 · DOI · Paper page
  11. Klegeris, 2007, Therapeutic approaches to inflammation in neurodegenerative disease, Current Opinion in Neurology, 20, 351, 10.1097/WCO.0b013e3280adc943 · DOI · Paper page
  12. Reines, 2004, Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study, Neurology, 62, 66, 10.1212/WNL.62.1.66 · DOI · Paper page
  13. Scharf, 1999, A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease, Neurology, 53, 197, 10.1212/WNL.53.1.197 · DOI · Paper page
  14. Smith, 2008, Inflammation in Parkinson's disease: an update, Current Opinion in Investigational Drugs, 9, 478
  15. Szekely, 2004, Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review, Neuroepidemiology, 23, 159, 10.1159/000078501 · DOI · Paper page
  16. Tabet, 2002, Indomethacin for Alzheimer's disease, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003673 · DOI · Paper page
  17. Tabet, 2003, Ibuprofen for Alzheimer's disease, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD004031 · DOI
  18. Wersinger, 2006, An inflammatory pathomechanism for Parkinson's disease?, Current Medicinal Chemistry, 13, 591, 10.2174/092986706776055760 · DOI · Paper page
  19. Whitton, 2007, Inflammation as a causative factor in the aetiology of Parkinson's disease, British Journal of Pharmacology, 150, 963, 10.1038/sj.bjp.0707167 · DOI · Paper page

Cited by

See all 120

Metadata

Authors
Rees, K., Stowe, R., Patel, S., Ives, N., Breen, K., Clarke, C. E., & Ben-Shlomo, Y.
Venue
Cochrane Database of Systematic Reviews
Published
2010-04-14
ISSN
1361-6137 (ISSN-L)
OpenAlex
W4234799259
Cited by
120
References
7
Type
reference entry
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies. https://app.cochat.ai/papers/10.1002/14651858.cd008454
The paper
Rees, K., Stowe, R., Patel, S., Ives, N., Breen, K., Clarke, C. E., & Ben-Shlomo, Y. (2010). Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd008454

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.